BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 25889045)

  • 1. An update on the genetic architecture of hyperuricemia and gout.
    Merriman TR
    Arthritis Res Ther; 2015 Apr; 17(1):98. PubMed ID: 25889045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects.
    Takei R; Cadzow M; Markie D; Bixley M; Phipps-Green A; Major TJ; Li C; Choi HK; Li Z; Hu H; ; Guo H; He M; Shi Y; Stamp LK; Dalbeth N; Merriman TR; Wei WH
    J Hum Genet; 2021 Feb; 66(2):161-169. PubMed ID: 32778763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Influences on Hyperuricemia and Gout.
    Merriman T
    Rheum Dis Clin North Am; 2017 Aug; 43(3):389-399. PubMed ID: 28711141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of gout.
    Choi HK; Zhu Y; Mount DB
    Curr Opin Rheumatol; 2010 Mar; 22(2):144-51. PubMed ID: 20110790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes.
    Matsuo H; Yamamoto K; Nakaoka H; Nakayama A; Sakiyama M; Chiba T; Takahashi A; Nakamura T; Nakashima H; Takada Y; Danjoh I; Shimizu S; Abe J; Kawamura Y; Terashige S; Ogata H; Tatsukawa S; Yin G; Okada R; Morita E; Naito M; Tokumasu A; Onoue H; Iwaya K; Ito T; Takada T; Inoue K; Kato Y; Nakamura Y; Sakurai Y; Suzuki H; Kanai Y; Hosoya T; Hamajima N; Inoue I; Kubo M; Ichida K; Ooyama H; Shimizu T; Shinomiya N
    Ann Rheum Dis; 2016 Apr; 75(4):652-9. PubMed ID: 25646370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic basis of hyperuricaemia and gout.
    Merriman TR; Dalbeth N
    Joint Bone Spine; 2011 Jan; 78(1):35-40. PubMed ID: 20472486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCG2/BCRP dysfunction as a major cause of gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Suzuki H; Hosoya T; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1117-28. PubMed ID: 22132966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCG2 dysfunction increases the risk of renal overload hyperuricemia.
    Matsuo H; Takada T; Nakayama A; Shimizu T; Sakiyama M; Shimizu S; Chiba T; Nakashima H; Nakamura T; Takada Y; Sakurai Y; Hosoya T; Shinomiya N; Ichida K
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):266-74. PubMed ID: 24940678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of hyperuricaemia and gout.
    Reginato AM; Mount DB; Yang I; Choi HK
    Nat Rev Rheumatol; 2012 Oct; 8(10):610-21. PubMed ID: 22945592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis.
    Lukkunaprasit T; Rattanasiri S; Turongkaravee S; Suvannang N; Ingsathit A; Attia J; Thakkinstian A
    BMC Med Genet; 2020 Oct; 21(1):210. PubMed ID: 33087043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank.
    Sandoval-Plata G; Morgan K; Abhishek A
    Ann Rheum Dis; 2021 Sep; 80(9):1220-1226. PubMed ID: 33832965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of ABCG2 dysfunction as a major factor contributing to gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Takada Y; Okada C; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1098-104. PubMed ID: 22132963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ROLE OF SLC2A9 AND ABCG2 GENE POLYMORPHISMS IN ORIGIN OF HYPERURICEMIA AND GOUT].
    Fadieieva A; Prystupa L; Pogorelova O; Kirichenko N; Dudchenko I
    Georgian Med News; 2016 Mar; (252):79-83. PubMed ID: 27119840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.
    Jing J; Ekici AB; Sitter T; Eckardt KU; Schaeffner E; Li Y; Kronenberg F; Köttgen A; Schultheiss UT
    Sci Rep; 2018 Sep; 8(1):13184. PubMed ID: 30181573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
    Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout.
    Kawamura Y; Nakaoka H; Nakayama A; Okada Y; Yamamoto K; Higashino T; Sakiyama M; Shimizu T; Ooyama H; Ooyama K; Nagase M; Hidaka Y; Shirahama Y; Hosomichi K; Nishida Y; Shimoshikiryo I; Hishida A; Katsuura-Kamano S; Shimizu S; Kawaguchi M; Uemura H; Ibusuki R; Hara M; Naito M; Takao M; Nakajima M; Iwasawa S; Nakashima H; Ohnaka K; Nakamura T; Stiburkova B; Merriman TR; Nakatochi M; Ichihara S; Yokota M; Takada T; Saitoh T; Kamatani Y; Takahashi A; Arisawa K; Takezaki T; Tanaka K; Wakai K; Kubo M; Hosoya T; Ichida K; Inoue I; Shinomiya N; Matsuo H
    Ann Rheum Dis; 2019 Oct; 78(10):1430-1437. PubMed ID: 31289104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease.
    Stark K; Reinhard W; Grassl M; Erdmann J; Schunkert H; Illig T; Hengstenberg C
    PLoS One; 2009 Nov; 4(11):e7729. PubMed ID: 19890391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of ABCG2 and SLC2A9 gene polymorphisms in gouty arthritis in a Korean population.
    Kim YS; Kim Y; Park G; Kim SK; Choe JY; Park BL; Kim HS
    Korean J Intern Med; 2015 Nov; 30(6):913-20. PubMed ID: 26552468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.